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Editorial
Our purpose in this Bulletin is to focus on some issues
that have been at the centre of debate in the health field
during recent years. In this area there are many
principles that apply equally to developing and
developed countries and, while the majority of the
articles concern the Third World, two are included
about industrialised countries to make this point more
concrete. We start with one of them.
It is conventional wisdom these days that health is a
product of many factors, of which health care as such
is only one, if a major one. The importance of social
and economic conditions for health is well established
and is most associated now with the present problems
of Third World underdevelopment. Yet much of the
evidence for the great significance of the social
determinants of health comes from the historical
experience of the now developed countries. In
addition, it is being increasingly recognised that mass
health problems also have a social basis in the
industrialised world, where socioeconomic factors
continue to affect the health of populations adversely,
especially the disadvantaged classes. Thus though the
pattern of disease and the nature of the social factors
differ as between the developing and developed
countries, in both contexts socioeconomic and
political influences on health have been, and are, very
great, and call for a broad approach to health
problems involving both social and technical
(medical) interventions. This overarching argument is
the theme of the first article by Gray, who reviews the
historical and current health experience of Britain and
points out its relevance to both developed and
developing world situations.
Given the many factors that affect health, intersectoral
cooperation has become one of the shiboleths of the
primary health care (PHC) approach, but it is an idea
that is much more acknowledged in theory than acted
on in practice. In the second article, de Kadt looks at
some of the operational aspects of intersectorality for
health in developing countries, and links that question
with the necessity for government decentralisation
and community participation.
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Intersectoral cooperation is not the only aspect of
PHC that is still more spoken about than practised,
and the next two articles concern the politics of limited
implementation. The first of these, by de Macêdo (now
Director of the Pan-American Health Organisation)
and Vieira, is a case study of Brazil. It unfolds the
unhappy story of how a proposed PHC strategy for
the country met an untimely end and analyses in detail
the political forces that led to the early demise. While
the case of Brazil may be an extreme one, it illustrates
graphically the general point that the implementation
of PHC - as distinct from its rhetoric - is far from
straightforward in political terms. This is the theme of
the article by Segall, who ascribes the slow progress of
PHC in most countries to the strength of opposition
forces that are insufficiently recognised and countered.
After analysing the political qualities of PHC, he
proposes some lines of action that may be adopted by
PHC protagonists.
After these discussions of PHC politics come two
articles on health economics. Since the Alma Ata
Declaration the PHC approach has been adopted as
official policy by most developing countries, but a
major problem coming more and more to the fore is
how to finance it. This is the subject of the article by
Gish, who shows that the different modes of financing
health care - themselves a reflection of the economic
and political profile of a society - greatly affect the
provision, organisation and utilisation of health
services, and thereby influence health care costs.
Nevertheless, whatever the system of health care, and
however rich a country may be, health resources are
always limited and they should be used efficiently.
This is the theme of the second economics article, by
Maynard, who - using a market model of analysis -
looks at the efficiency issue in the health systems of
developed Western countries, where the availability of
the necessary data is more conducive to this approach.
This first set of articles is rounded off by a personal
statement by Lambo, the Deputy Director-General
of WHO, who addresses what he sees as the moral
imperative involved in resolving the health and
development problems of the Third World.
The final three articles concern one of the areas that is
a well recognised 'hot spot' in the health field:
pharmaceuticals, especially in relation to the develop-
ing countries. Rather than retreading the undoubted,
but well-worn, ground of the harmful practices of the
transnational pharmaceutical corporations, the articles
describe what responses can be and are being made by
Third World countries, individually and collectively.
Two of the articles are by ex-Ministers of Health. The
first is by Valdivieso, who describes an early
experience of instituting a national formulary in Chile
in the 1960s, with the opposition it generated and its
subsequent declining fate under the military regime.
Martins then describes the considerable achievements
of pharmaceutical policies in Mozambique since
independence, with special reference again to the
importance of a national formulary and generic
prescribing, as well as of a centralised system of state
drug procurement.
Much credit is often given to the UN specialised
agencies for promoting rational pharmaceutical
policies in developing countries; WHO's limited list of
essential drugs is perhaps the best known example.
This acknowledgement is fair, but what is much less
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well-known are the efforts of the Third World
countries themselves, particularly the non-aligned
group, and of UNCTAD. They were largely
responsible in the mid-1970s for building up the head
of political pressure that was needed to set the recent
international events in the pharmaceutical field in
motion. The pressure is indeed still needed to keep them
on the move in all their technical, organisational and
political aspects. This is the story told in the last
article, by Patel, Director of UNCTAD's technology
division, who makes it clear that some of the most
critical episodes in the drugs saga are still to come.
In compiling this Bulletin we have been guided by the
notion that health and health care are in the first place
social phenomena, relating to and reflecting other
characteristics of a society. At the present time it is
advances on the economic, political and social fronts
that will mainly determine improvements in health
and progress towards equity in health care, and that
will create the conditions for the world's peoples to
benefit properly from the technical advances already
made - and yet to be made - in health and medicine.
We have tried to cover some of the issues in health
policy and practice where movement is most needed to
facilitate the next significant steps forward.
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